查詢結果分析
相關文獻
- Unusual Case of Colitis Induced by Cytomegalovirus Reactivation after Autologous Peripheral Blood Stem Cell Transplantation in a Patient with Multiple Myeloma
- Experience of Using FK 506 as a Rescue Therapy for Refractory Hepatic Allograft Rejection
- Kaposi's Sarcoma in Eastern Taiwan: An Analysis of 13 Cases
- 鼻腔髓外漿細胞瘤--病例報告
- 處方評估及用藥檢討:腎移植後急性排斥之治療
- 自體免疫疾病患者接受免疫抑制劑治療所引發的感染併發症
- Multiple Myeloma Presenting with a Paraspinal Tumor and Malignant Effusion: Case Report
- Immunoglobulin D Multiple Myeloma: A Case Report
- Malignancy Following Renal Transplantation
- 多發性骨髓瘤--病例報告
頁籤選單縮合
題 名 | Unusual Case of Colitis Induced by Cytomegalovirus Reactivation after Autologous Peripheral Blood Stem Cell Transplantation in a Patient with Multiple Myeloma=多發性骨髓瘤患者經自體周邊血液幹細胞移植後產生少見巨細胞病毒再活化引起之結腸炎 |
---|---|
作 者 | 黃淑雲; 張平穎; 彭成立; 黃緯琛; 林信仲; 陳宇欽; | 書刊名 | 臺灣癌症醫學雜誌 |
卷 期 | 28:3 2012.09[民101.09] |
頁 次 | 頁140-146 |
分類號 | 416.245 |
關鍵詞 | 自體造血幹細胞移植; 巨細胞病毒結腸炎; 免疫抑制; 多發性骨髓瘤; Autologous peripheral blood stem cell transplantation; CMV colitis; Immunosuppression; Multiple myeloma; |
語 文 | 英文(English) |
中文摘要 | 巨細胞病毒(CMV)的感染或再活化,仍是免疫受損患者最常發生的併發症,如那 些接受高免疫抑制藥物,或接受異體幹細胞移植(SCT)的病人,尤其是出現在病患產生 移植體對抗宿主疾病時更易發生。相對地,這情形較少發生在自體幹細胞移植的病人。 本個案是一位 63 歲台灣女性,患有多發性骨髓瘤,經自體造血幹細胞移植成功後, 產生發燒、水瀉和腹痛症狀。此病人的大腸鏡檢驗發現整條結腸有多處結腸炎。由血漿 中巨細胞病毒聚合酶鏈反應檢測陽性結果與病變處組織切片染色而確診為巨細胞病毒性 腸炎。我們開始使用 gancyclovir 抗病毒藥治療,她的發燒、腹瀉和腹痛症狀逐漸消退, 因此她在自體造血幹細胞移植後第 74 天出院。在自體幹細胞移植後腹瀉的鑑別診斷,通 常不會被認為是巨細胞病毒感染性結腸炎,且沒有內視鏡評估和病理證實可能不容易被 診斷。我們相信,這案例顯示有必要考慮此病人在自體幹細胞移植後持續性腹瀉的原因, 以便在最主要病因排除後,盡可能在合理時間內做適當的診斷和治療。 |
英文摘要 | Cytomegalovirus (CMV) infection or reactivation remains one of the most common complications in immunocompromised patients such as those receiving highly immunosuppressive drugs or undergoing allogeneic stem cell transplantation (SCT), especially in the presence of advanced graft-versus-host disease. In contrast, it occurs much less frequently in autologous SCT. Here we report a 63-year-old Taiwanese woman with multiple myeloma who suffered from progressive watery diarrhea and abdominal pain after successful engraftment of autologous peripheral blood stem cells (PBSC). The patient’s colonoscopy showed multifocal colitis throughout the colon. A diagnosis of CMV colitis was confirmed by demonstration of CMV viremia using polymerase chain reaction and biopsy of the lesions. Given this diagnosis, we started treatment with intravenous gancyclovir. Her fever, diarrhea and abdominal pain gradually subsided, and she was discharged on day 74 after autologous PBSCT. CMV colitis is not typically considered in the differential diagnosis of diarrhea in patients following autoPBSCT and may not be easy to diagnose without endoscopic evaluation and pathological confirmation. We believe that our case demonstrates the need to consider this entity as a potential cause of persistent diarrhea in patients undergoing autoPBSCT so that appropriate diagnostic and therapeutic interventions may be instituted in a timely fashion after more common etiologies have been ruled out. |
本系統中英文摘要資訊取自各篇刊載內容。